✦ LIBER ✦

Alternating sequential intracarotid bcnu and cisplatin in recurrent malignant glioma

✍ Scribed by Lisa R. Rogers; Richard J. Lederman; Joseph B. Purvis; Scott A. Rosenbloom; Robert L. Tomsak; Melinda L. Estes; Michelle Magdinec; Sharon V. Medendorp; James M. Boyett

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 780 KB
Volume: 68
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19910701)68:1<15::aid-cncr2820680104>3.0.co;2-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravenous BCNU and AZQ in patients wit

Intravenous BCNU and AZQ in patients with recurrent malignant gliomas

✍ W.K.A. Yung; M.I. Harris; J.M. Bruner; L.G. Feun 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 293 KB

Twenty-four patients with recurrent malignant glioma were treated with intravenous BCNU (80 mg/m2/ day x 3 days) alternating with AZQ (8 mg/mZ/day x 5 days) every 6--8 weeks. Twenty patients received two or more courses of chemotherapy, ten anaplastic astrocytomas (AA), eight glioblastomas (GBM), an